Xvivo Perfusion AB (publ) (LON:0RKL)

Xvivo Perfusion AB Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 20, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,073	1,112	810	435	671	804
Market Cap Growth	37.21%	37.21%	86.41%	-35.22%	-16.57%	120.04%
Enterprise Value	1,045	1,081	766	410	648	751
Last Close Price	34.15	35.29	25.72	14.78	22.75	28.27
PE Ratio	86.38	89.46	113.04	296.26	1007.77	-
PS Ratio	18.73	18.73	17.37	13.15	31.79	50.14
PB Ratio	7.14	7.14	5.34	3.82	6.39	8.94
P/TBV Ratio	10.80	10.80	7.84	6.86	10.06	11.59
P/FCF Ratio	379.48	379.48	3172.09	564.50	-	-
P/OCF Ratio	138.41	138.41	224.23	195.98	-	-
EV/Sales Ratio	17.10	18.21	16.42	12.40	30.71	46.80
EV/EBITDA Ratio	94.01	100.14	515.41	387.15	-	-
EV/EBIT Ratio	159.15	169.52	1818.08	1156.31	-	-
EV/FCF Ratio	356.74	369.00	2998.27	532.54	-	-
Debt / Equity Ratio	0.02	0.02	0.02	0.01	0.00	0.01
Debt / EBITDA Ratio	0.23	0.23	1.06	0.51	-	-
Debt / FCF Ratio	0.84	0.84	9.61	1.03	-	-
Asset Turnover	0.36	0.36	0.30	0.25	0.19	0.20
Inventory Turnover	1.12	1.12	1.23	1.29	1.02	0.97
Quick Ratio	3.30	3.30	4.94	2.60	4.43	5.51
Current Ratio	4.58	4.58	6.14	3.47	5.24	6.41
Return on Equity (ROE)	8.40%	8.40%	5.44%	1.36%	0.71%	-5.52%
Return on Assets (ROA)	2.40%	2.40%	0.17%	0.17%	-0.87%	-3.09%
Return on Capital (ROIC)	2.65%	2.65%	0.20%	0.20%	-1.02%	-3.45%
Return on Capital Employed (ROCE)	3.97%	3.97%	0.26%	0.28%	-	-
Earnings Yield	1.16%	1.12%	0.88%	0.34%	0.10%	-0.48%
FCF Yield	0.27%	0.26%	0.03%	0.18%	-0.27%	-0.17%
Buyback Yield / Dilution	-5.73%	-5.73%	-1.39%	-2.04%	-6.49%	-1.39%
Total Shareholder Return	-5.73%	-5.73%	-1.39%	-2.04%	-6.49%	-1.39%

Source: S&P Capital IQ. Standard template. Financial Sources.